Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis (2022)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/16000617.0071-2022
Publication URI: http://dx.doi.org/10.1183/16000617.0071-2022
Type: Journal Article/Review
Parent Publication: European Respiratory Review
Issue: 166